期刊
FRONTIERS IN IMMUNOLOGY
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.00737
关键词
MDSC; glioma; immunosuppression; tumor microenvironment; therapeutic target
类别
资金
- National Natural Science Foundation of China [81873740, 81601376]
- Shaanxi Youth Talents Project, Scientific Research Program - Shaanxi Provincial Education Department [19JS057]
- Natural Science Basic Research Plan in Shaanxi Province of China [2020JQ-879, 2020JQ-877]
- Xi'an Medical University's Key Disciplines of Molecular Immunology [2018GJFY05, 2018DOC02, 2018PT08, 18NBZD08, 18NBZD09]
- Foundation of Xi'an Medical University's [2018GJFY05, 2018DOC02, 2018PT08, 18NBZD08, 18NBZD09]
- Youth Innovation Team of Shaanxi Universities
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid progenitor and precursor cells at different stages of differentiation, which play an important role in tumor immunosuppression. Glioma is the most common and deadliest primary malignant tumor of the brain, and ample evidence supports key contributions of MDSCs to the immunosuppressive tumor microenvironment, which is a key factor stimulating glioma progression. In this review, we summarize the source and characterization of MDSCs, discuss their immunosuppressive functions, and current approaches that target MDSCs for tumor control. Overall, the review provides insights into the roles of MDSC immunosuppression in the glioma microenvironment and suggests that MDSC control is a powerful cellular therapeutic target for currently incurable glioma tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据